Live from the NIH registry
Studies recruiting near Indio right now
Top 25 of 68 recruiting studies, sorted by proximity — each links to its official registry page
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Palm Springs, California (19.0 mi)
· Sponsor: Akero Therapeutics, Inc
Physica System Total Knee Replacement Registry Study
Osteoarthritis, Knee, Traumatic Arthritis
N/A
Interventional 800 participants sought
Eisenhower Desert Orthopedics Center - Harry and Diane Rinker Bldg — Rancho Mirage, California (10.2 mi)
· Sponsor: Limacorporate S.p.a
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Obesity, Overweight
Phase 3
Interventional 1,980 participants sought
Desert Oasis Healthcare Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Eli Lilly and Company
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: National Cancer Institute (NCI)
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Comprehensive Cancer Center at Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: Agendia
Shield Post-Approval Study Protocol
Colo-rectal Cancer
N/A
Observational 3,375 participants sought
Desert Oasis Healthcare Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Guardant Health, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: SWOG Cancer Research Network
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
Desert Oasis Healthcare Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Eli Lilly and Company
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 920 participants sought
Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: Eli Lilly and Company
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,000 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management
Diabetic Foot Ulcer
N/A
Interventional 240 participants sought
DPMG — Palm Springs, California (19.0 mi)
· Sponsor: Legacy Medical Consultants
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Low-grade NMIBC, FGFR Gene Amplification
Phase 2
Interventional 90 participants sought
Eisenhower Medical Associates — Rancho Mirage, California (10.2 mi)
· Sponsor: Tyra Biosciences, Inc
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
New Onset Generalized Myasthenia Gravis (gMG)
Phase 4
Interventional 30 participants sought
Samir Macwan, M.D., Inc. (S corporation) — Rancho Mirage, California (10.2 mi)
· Sponsor: argenx
Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry
Soft Tissue Lesion
N/A
Observational 1,000 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Galvanize Therapeutics, Inc.
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Overweight
Phase 3
Interventional 400 participants sought
Desert Oasis Healthcare — Palm Springs, California (19.0 mi)
· Sponsor: Novo Nordisk A/S
Phase I Human Analytics (HALO) Study
Cardiovascular Diseases, Cancer
N/A
Observational 2,000 participants sought
Desert Medical Imaging — Indian Wells, California (6.3 mi)
· Sponsor: HALO Diagnostics
Study of Personalized Cancer Therapy to Determine Response and Toxicity
Cancer
N/A
Observational 10,000 participants sought
Eisenhower Medical Center, Lucy Curci Cancer Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Shu Mei Kato
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Chronic Inflammatory Demyelinating Polyneuropathy, CIDP
Phase 3
Interventional 160 participants sought
Samir Macwan, M.D., Inc. (S corporation) — Rancho Mirage, California (10.2 mi)
· Sponsor: argenx
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Rancho Mirage, California (10.2 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Regeneron Pharmaceuticals
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
Symptomatic Venous Thromboembolism (VTE)
Phase 3
Interventional 2,000 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Regeneron Pharmaceuticals
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Diabetes Mellitus, Type 2, PreDiabetes
N/A
Interventional 7,500 participants sought
HALO Diagnostics — Indian Wells, California (6.3 mi)
· Sponsor: Cleerly, Inc.